Danton H ODay
Overview
Explore the profile of Danton H ODay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
502
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
ODay D
Int J Mol Sci
. 2025 Jan;
25(24.
PMID: 39769187
The predominant neurodegenerative diseases, Alzheimer's disease, Parkinson's disease, dementia with Lewy Bodies, Huntington's disease, amyotrophic lateral sclerosis, and frontotemporal dementia, are rarely pure diseases but, instead, show a diversity of...
2.
ODay D
Biomolecules
. 2024 Jul;
14(7).
PMID: 39062567
Finding an effective treatment for traumatic brain injury is challenging for multiple reasons. There are innumerable different causes and resulting levels of damage for both penetrating and non-penetrating traumatic brain...
3.
ODay D
Biomolecules
. 2024 Feb;
14(2).
PMID: 38397410
Calcium dyshomeostasis is an early critical event in neurodegeneration as exemplified by Alzheimer's (AD), Huntington's (HD) and Parkinson's (PD) diseases. Neuronal calcium homeostasis is maintained by a diversity of ion...
4.
ODay D
J Clin Med
. 2023 Nov;
12(22).
PMID: 38002659
Seven major neurodegenerative diseases and their variants share many overlapping biomarkers that are calmodulin-binding proteins: Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), frontotemporal lobar dementia (FTD), Huntington's disease (HD), Lewy...
5.
ODay D
Curr Issues Mol Biol
. 2023 Aug;
45(8):6246-6261.
PMID: 37623212
A multifactorial syndrome, Alzheimer's disease is the main cause of dementia, but there is no existing therapy to prevent it or stop its progression. One of the earliest events of...
6.
ODay D
Biomolecules
. 2023 May;
13(4).
PMID: 37189425
An increasing number of plant-based herbal treatments, dietary supplements, medical foods and nutraceuticals and their component phytochemicals are used as alternative treatments to prevent or slow the onset and progression...
7.
ODay D
Int J Mol Sci
. 2023 Jan;
24(2).
PMID: 36674908
Calmodulin (CaM) and a diversity of CaM-binding proteins (CaMBPs) are involved in the onset and progression of Alzheimer's disease (AD). In the amyloidogenic pathway, AβPP1, BACE1 and PSEN-1 are all...
8.
ODay D
Curr Issues Mol Biol
. 2022 Nov;
44(11):5802-5814.
PMID: 36421678
Neurodegeneration leads to multiple early changes in cognitive, emotional, and social behaviours and ultimately progresses to dementia. The dysregulation of calcium is one of the earliest potentially initiating events in...
9.
ODay D, Huber R
BMC Neurosci
. 2022 Mar;
23(1):10.
PMID: 35246032
Calcium dysregulation ("Calcium Hypothesis") is an early and critical event in Alzheimer's and other neurodegenerative diseases. Calcium binds to and regulates the small regulatory protein calmodulin that in turn binds...
10.
ODay D
Int J Mol Sci
. 2020 Oct;
21(19).
PMID: 33027906
The integral role of calmodulin in the amyloid pathway and neurofibrillary tangle formation in Alzheimer's disease was first established leading to the "Calmodulin Hypothesis". Continued research has extended our insight...